Prostate Biomarkers

Micrograph showing the most common prostate cancer

MedTech

GE signs up to make Blue Earth cancer imaging agent

The deal moves Blue Earth a step closer to making its recently approved prostate cancer agent available in its home country.

Nick Paul Taylor Oct 2, 2017 9:53am

Micrograph showing the most common prostate cancer

Researchers create test to predict response to Xtandi, Zytiga

May 5, 2017 9:24am